Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug-Coated Balloons Fuel Multibillion-Dollar Hopes

Jan 30 2013

Related Content

Drug-Eluting Balloons: Promise Versus Practicalities

Jun 01 2011

As TAVI Advances, Adjunctive Devices Multiply

Dec 16 2011

Cardionovum: As DEBs Heat Up, Who Needs The US Market?

May 23 2012

The Next Wave in Peripheral Vascular Interventions

Mar 01 2010

Bard Buys Lutonix For Lead In Race To U.S. Market With Drug-Coated Balloon

Jan 02 2012

Fractional Flow Reserve Makes Inroads In Interventional Cardiology

Jan 27 2012

Renal Denervation Sparks Device Market Gold Rush

May 25 2012

COURAGE Suggests Stents Do Not Benefit Stable Coronary Disease Patients

Apr 02 2007

Drug-Eluting Balloons: Coming of Age in the Periphery

Mar 01 2010

Don’t Stent Stable Patients First, New Meta-Analysis Affirms

Mar 05 2012

Stents Vs. Balloons Question For Peripheral Artery Disease Gets Attention At Veith

Nov 26 2012

Doc Payments For Coronary Stenting Will Drop Next Year, But Will Better Reflect Procedure Complexity

Nov 19 2012

Related Companies

Harvard University

Bayer AG

Bayer AG

C.R. Bard

BIOTRONIK AG

Medtronic plc

B. Braun Melsungen AG

B. Braun Melsungen AG

Boston Scientific Corporation

Columbia University

Columbia University

Abbott

Abbott

Medtronic plc

Covidien plc

CV Ingenuity Corp.

Orchestra BioMed Holdings, Inc.

Micell Technologies, Inc.

Royal Philips

QT Vascular Ltd.

Vascular Magnetics, Inc.

ThermopeutiX Inc.

Spectranetics Corporation

Terumo Corporation

Veryan Medical Ltd.

Cook Group, Inc.

Cook Group, Inc.

Translumina GmbH

Biosensors International Group Ltd.

Tryton Medical, Inc.

480 Biomedical, Inc.

Arsenal Medical, Inc.

Additional Topics

More from Archive

More from Medtech Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window